niftify.in

Business Standard

Jhunjhunwala Portfolio: This pharma stock has zoomed over 100% in 6 months

Shares of Jubilant Pharmova surged 12 per cent on the BSE in Friday's intra-day trade to hit a new high of Rs 1,169.55, in an otherwise subdued market.

Business Standard

Jubilant Pharmova hits all time high on receiving 'VAI' tag for US facility

Jubilant Pharmova share price rose as much as 4.2 per cent, touching its all time high at Rs 1060.15 per share on the BSE in early hours of Wednesday's intraday deals

Business Standard

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

Jubilant Pharmova advanced 1.60% to Rs 1,033.55 after its subsidiary, Jubilant HollisterStier LLC's (JHS) manufacturing facility located at Spokane, Washington (USA) received classification of "Voluntary Action Indicated" from USFDA.

CNBC TV18

Jubilant Pharmova subsidiary gets US FDA note for Washington unit

Following an audit conducted from May 28-June 6, 2024, the US FDA has classified the drug firm's Spokane, Washington, manufacturing facility's inspection status as 'voluntary action indicated' (VAI). Shares of Jubilant Pharmova Ltd ended at ₹1,014.10, down by ₹16.30, or 1.58%, on the BSE.

The Economic Times

Technical Breakout Stocks: How to trade Hindustan Unilever, Jubilant Pharmova and Glenmark Life on Tuesday?

Indian markets ended higher on Monday, with the S&P BSE Sensex up over 370 points and Nifty50 maintaining 24,900 levels. Gains were seen in consumer durables, banks, and FMCG, while sectors like PSU and energy saw declines.

Business Standard

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are among the other gainers in the BSE's 'A' group today, 09 September 2024.

The Economic Times

How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

​We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.

CNBC TV18

Jubilant Pharmova's subsidiary to acquire 80% stake in Pierre Fabre's R&D centre in France

Shares of Jubilant Pharmova Ltd ended at ₹854.90, down by ₹7.05, or 0.82% on the BSE.

Mint

Rakesh Jhunjhunwala Multibagger stocks- Geojit, NCC are among 4 key stocks having returned up to 123% over last year

Rakesh Jhunjhunwala Stocks: Geojit Financial Services, Raghav Productivity Enhancers Ltd, Jubilant Pharmova , NCC Ltd are the stocks in the Rakesh Jhunjhunwala and Associates Portfolio that have given Multibagger returns during last one year. Check details change in shareholdings.

The Economic Times

Jubilant Pharmova's US arm prepays Rs 626 crore term loan

Jubilant Pharmova's US subsidiary secured a $75 million term loan, as of March 31, 2024, the company's gross debt stood at Rs. 3,414 crore and net debt at Rs. 2,457 crore. In FY24, the company reported revenue of Rs. 6,772 crore and a net profit of Rs. 195 crore. The net debt to Ebitda ratio improved from 2.93x to 2.48x.